Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Putting up a Shelf
View:
Post by UglyKidStock on Apr 22, 2021 11:07am

Putting up a Shelf

Is this a smart as a fox move or a signal of danger.    This filing gives them the opportunity to sell 40 million in shares anytime in the next 12 months.    If management is confident the next 3 quarterly reports will be positive then every 3 months the share price will increase.   Say by Sept it is 2.70 and you sell 20 million shares at that and put it directly on the debt.  Isn't that a net positive for enterprise value?    Say in  Jan 2022 30million share outstanding against 54 million less debt?    Any one with extensive Finance knowledge care to comment?   I could see it as dangerous if the company was shrinking or not profitable.    They don't need to sell shares but probably sure as hell should if share price zooms again.  I'm holding for 2 years to see how this plays out.  It's a gamble but the details seem interesting.    The danger would be 40 million shares added for an overpriced acquisition.   Intelligent comments welcome.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities